Richardpruen (talk | contribs) (→Should it be the choice and pace of any cessation attempt of the users?: Reworded and added context) |
Richardpruen (talk | contribs) (Removed double template) |
||
| Line 16: | Line 16: | ||
* E-cigarette abstinence rate in the varenicline + counseling group was 34.3%, significantly higher than the abstinence rate of 17.2% in the placebo + counseling group. Notably, no subject in the study relapsed to tobacco cigarette smoking. | * E-cigarette abstinence rate in the varenicline + counseling group was 34.3%, significantly higher than the abstinence rate of 17.2% in the placebo + counseling group. Notably, no subject in the study relapsed to tobacco cigarette smoking. | ||
* '''Note:''' Varenicline has risks, it should be discussed with a doctor aware of vaping, if the risks outweigh the benefits of stopping vaping (as they may in many vapers), then it would not be warranted. | * '''Note:''' Varenicline has risks, it should be discussed with a doctor aware of vaping, if the risks outweigh the benefits of stopping vaping (as they may in many vapers), then it would not be warranted. | ||
{{Stub}} | |||
[[Category:Studies, Surveys, and Papers]] | [[Category:Studies, Surveys, and Papers]] | ||
edits